Skip to content
MatchScript
Menu

Ranked by the Match Score

Alternatives to SexyMD

SexyMD scores 70 on our six-factor Match Score (ranked #126 of 528). Here are the providers we'd weigh against it, ranked by that same honest model. Or take the quiz for your personalized match.

Grade C

Enhance MD

#20

A transparent, tiered compounded program with dose-flat pricing, built-in lab testing every six months, and NAD+ care alongside your GLP-1.

Sema
$271/mo
Tirz
$358/mo
Coverage
39 states
Grade C

Invigor Medical

#33

An established telehealth pharmacy with a broad metabolic and hormone catalog and strong support.

Sema
$245/mo
Tirz
$380/mo
Coverage
All 50 states
Grade A−

CoreAge Rx

#1#1 overall

The best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.

Sema
$99/mo at every dose
Tirz
$149/mo at every dose
Coverage
All 50 states
Grade B

Eden

#3

A polished, high-disclosure compounded program with strong nationwide coverage and hands-on support.

Sema
$198/mo
Tirz
$298/mo
Coverage
All 50 states

Regulatory notice

FDA issued Eden Health International Inc. dba Eden a warning letter in June 2026. You can read it in FDA's warning-letter database. We still list Eden, and we may earn a commission if you start care through the link on this page.

Grade B−

yourEra

#13

A personalized-health brand that lists its GLP-1 prices out loud — both molecules, plus NAD+ and microdosing, with an optional coaching-and-labs bundle, nationwide.

Sema
$199/mo
Tirz
$263/mo
Coverage
All 50 states
Grade C

REMEVi

#35

A straightforward, nationwide program with both molecules at mid-market pricing and LegitScript certification.

Sema
$219/mo
Tirz
$319/mo
Coverage
All 50 states
Grade C

Henry Meds

#50

A flat-fee compounded pioneer — simple, transparent model, but priced at the higher end now.

Sema
$301/mo
Tirz
$301/mo
Coverage
All 50 states
Grade C

Hims & Hers

#25

Mass-market, app-first weight program with nationwide reach and consumer-grade polish.

Sema
$199/mo
Tirz
$299/mo brand Zepbound
Coverage
All 50 states

Regulatory notice

FDA issued Hims & Hers Health, Inc. dba Hims a warning letter in September 2025. You can read it in FDA's warning-letter database. We still list Hims & Hers, and we may earn a commission if you start care through the link on this page.

Not sure which fits you?

Answer six quick questions and we'll reweight the Match Score to your budget, format, timing, coverage and support — then rank every provider for you.

Take the quiz

Pricing, states and verification reflect each provider's public disclosures at last review; the Match Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← All comparisons